Dr. Jeff Stein, former President and
CEO of Trius Therapeutics and former Chairman of the Antibiotics
Working Group (AWG), today published a new blog post as a Key Opinion
Leader on The Chairman's Blog. TheChairmansBlog.com is an exclusive
online media publication that provides key executive officers and key
opinion leaders a unique platform to share insights about company and
Discussing the 10b5-1 trading plan, Dr.
Stein points out the effect of these plans on newly public biotech
companies, especially those with thinly traded stock. He gives advice
based on his experiences at Trius Therapeutics for newly public
companies setting up these trading plans, "Until the company
matures, think of your stock position more like a real estate holding
rather than a checking account with an ATM card." Read the full
blog post from Dr. Stein on TheChairmansBlog.com
TheChairmansBlog.com is an exclusive,
online media publication where publically and privatively held firms
alike share insights about their companies and industries.
TheChairmansBlog.com enables upper tier management to discuss issues
that are of importance to their stakeholders, shareholders, and
interested parties in an informal environment. In addition to
management`s insightful blog posts, TheChairmansBlog.com staff and
aggregate partners contribute articles on finance, technology,
health, and energy while providing updated market trends, news, and
Leave a comment...